共 30 条
Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study
被引:56
作者:
Andersson, Charlotte
[1
,2
]
Enserro, Danielle
[3
]
Sullivan, Lisa
[3
]
Wang, Thomas J.
[1
,2
,4
]
Januzzi, James L., Jr.
[5
]
Benjamin, Emelia J.
[1
,2
,6
,7
,8
]
Vita, Joseph A.
[9
,10
]
Hamburg, Naomi M.
[9
,10
]
Larson, Martin G.
[1
,2
]
Mitchell, Gary F.
[11
]
Vasan, Ramachandran S.
[1
,2
,6
,7
,8
]
机构:
[1] Boston Univ, Framingham Heart Study, Framingham, MA USA
[2] NHLBI, Framingham Heart Study, Framingham, MA USA
[3] Boston Univ, Dept Biostat, Framingham, MA USA
[4] Vanderbilt Univ, Div Cardiovasc Med, 221 Kirkland Hall, Nashville, TN 37235 USA
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA
[6] Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA
[7] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA
[8] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[9] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA
[10] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[11] Cardiovasc Engn Inc, Norwood, MA USA
来源:
关键词:
Vascular stiffness;
Endothelial function;
Biomarkers;
ST2;
GDF-15;
Troponin I;
General population;
GROWTH-DIFFERENTIATION FACTOR-15;
FLOW-MEDIATED DILATION;
ARTERIAL STIFFNESS;
SYSTOLIC HYPERTENSION;
AORTIC STIFFNESS;
SENSITIVE ASSAY;
PULSE PRESSURE;
ASSOCIATION;
MORTALITY;
ATHEROSCLEROSIS;
D O I:
10.1016/j.atherosclerosis.2016.02.013
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background and aims: Growth differentiation factor-15 (GDF-15), soluble (s) ST2, and high-sensitivity troponin-I (hs-TnI) are associated with incident cardiovascular disease (CVD) including heart failure, yet the underlying mechanisms are not fully understood. We investigated if GDF-15, sST2, and hs-TnI are related to subclinical vascular dysfunction in the community, which may explain the relations of these biomarkers with CVD. Methods: We evaluated 1823 Framingham Study participants (mean age 61 +/- 10 years, 54% women) who underwent routine assessment of vascular function. We related circulating GDF-15, sST2, and hs-TnI concentrations to measures of arterial stiffness (carotid-femoral pulse wave velocity, CFPWV; augmentation index; and forward pressure wave amplitude, FW), endothelial-dependent vasodilation (flow-mediated dilation, FMD), and baseline and hyperemic brachial flow velocities using linear regression adjusting for standard risk factors. Results: After multivariable adjustment, GDF-15 levels were positively associated with CFPWV (0.044 [95% confidence interval 0.007-0.081] standard deviation [SD] change per SD increase in log(e)[GDF-15], p = 0.02) and FW (0.076 [0.026-0.126] SD change per SD increase in log(e)[GDF-15], p = 0.003) and inversely related to FMD (-0.051 [-0.101-0.0003] SD change per SD increase in log(e)[GDF-15], p = 0.048). sST2 was positively associated with CFPWV (0.032 [0.0005-0.063] SD change per SD increase in log(e)[sST2], p = 0.046), and hs-TnI inversely associated with hyperemic flow velocity (-0.041 [-0.082 -0.0004] SD change per SD increase in log(e)[hs-TnI], p = 0.048). Conclusion: In our community-based investigation, individual cardiac stress biomarkers were differentially related to select aspects of vascular function. These findings may contribute to the associations of circulating GDF-15, sST2, and hs-TnI with incident CVD and heart failure. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:245 / 251
页数:7
相关论文